Chimeric Antigen Receptor T-Cell Therapy for T-Cell Acute Lymphocytic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 28
- By:
- Publication type:
- Article
Works matching IS 15430790 AND DT 2025 AND VI 23 AND IP 1
Results: 8
1
2
Management of Oligoprogressive and Oligopersistent Disease in Advanced NSCLC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 40
- By:
- Publication type:
- Article
3
Personalized Approaches to Breast Radiotherapy: Strategies for Treatment Refinement.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 30
- By:
- Publication type:
- Article
4
Novel Approaches to Optimization of Drug Dosages.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 26
- By:
- Publication type:
- Article
5
Professor of Medicine, Surgery, Pharmacology, and Cancer Biology Director of Research Duke Cancer Institute Center for Prostate and Urologic Cancers Durham, North Carolina.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 21
- By:
- Publication type:
- Article
6
The Role of CTLA-4 Inhibition in Immunotherapy for MSI-H/dMMR Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 18
- By:
- Publication type:
- Article
7
New Cell Surface Targets in Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 10
- By:
- Publication type:
- Article
8
Lumpers and Splitters.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 1, p. 8
- By:
- Publication type:
- Article